Syzygy Plasmonics is going to be competing in Gastech's new startup competition. Photo courtesy of Syzygy

Aglobal natural gas, LNG, hydrogen, low-carbon solutions, and climate technology convention is coming to Houston next month — but only one Houston startup is geared up for the event's new startup competition.

Gastech invited 20 promising companies for its inaugural Gastech Start-Up Competition, and 11 companies have signed on to participate so far. Houston-based Syzygy Plasmonics, which created and is scaling a sustainable photocatalytic reactor, is currently the only local company among the participants.

“Gastech's focus on creating a low-carbon, affordable energy future aligns perfectly with Syzygy's drive to produce low-carbon, low-cost hydrogen, liquid fuels, and syngas," Syzygy Plasmonics CEO Trevor Best says. "We can't wait to represent Houston as the only startup from the area to be included among the 11 finalists in the Gastech Climatetech Global Entrepreneur Competition.”

It's the first year Gastech, which was announced to be returning to Houston last year, is hosting the competition, which invited startups from the Gastech Hydrogen and Climatetech & AI hubs. The program will allow the participants to promote their projects, benchmark in a competitive setting, and receive critical feedback from experts.

The selected companies are innovating scalable solutions across technologies in climatetech, alternative fuels, industrial decarbonization, AI, hydrogen, and more. Each company will have five minutes to pitch and three minutes of feedback. The winner receives the Gastech 2024 Leading Start-up Trophy.

“We were very impressed by the ability of Syzygy to provide deep decarbonization technology which hit the mark on each of the requirements above – we hadn’t seen it before at Gastech and there is real potential to deliver at scale,” Simon Ford, vice president at Gastech, says.

The other selected and confirmed companies are:

  • General Galactic
  • Element One
  • Stars Technology
  • Modcon System
  • Fluid-7
  • Divigas
  • Gusty.ai
  • Omega Black
  • Kayrros
  • Mitis

The competition is in partnership with Houston Energy Transition Initiative and will take place beginning at 1:30 pm on Wednesday, September 18. Networking will follow the competition. Judges include Jane Stricker of the Houston Energy Transition Initiative, Mahdi Aladel and/or Bruce Niven of Aramco Ventures, and Daniel Palmer of Climate Investment.

------

This article originally ran on EnergyCapital.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston femtech co. debuts new lactation and wellness pods

mom pod

Houston-based femtech company Work&, previously known as Work&Mother, has introduced new products in recent months aimed at supporting working mothers and the overall health of all employees.

The company's new Lactation Pod and Hybrid Pod serve as dual-use lactation and wellness spaces to meet employer demand, the company shared in a news release. The compact pods offer flexible design options that can serve permanent offices and nearly all commercial spaces.

They feature a fully compliant lactation station while also offering wellness functionalities that can support meditation, mental health, telehealth and prayer. In line with Work&'s other spaces, the pods utilize the Work& scheduling platform, which prioritizes lactation bookings to help employers comply with the PUMP Act.

“This isn’t about perks,” Jules Lairson, Work& co-founder and COO, said in the release. “It’s about meeting people where they are—with dignity and intentional design. That includes the mother returning to work, the employee managing anxiety, and everyone in between.”

According to the company, several Fortune 500 companies are already using the pods, and Work& has plans to grow the products' reach.

Earlier this year, Work& introduced its first employee wellness space at MetroNational’s Memorial City Plazas, representing Work&'s shift to offer an array of holistic health and wellness solutions for landlords and tenants.

The company, founded in 2017 by Lairson and CEO Abbey Donnell, was initially focused on outfitting commercial buildings with lactation accommodations for working parents. While Work& still offers these services through its Work&Mother branch, the addition of its Work&Wellbeing arm allowed the company to also address the broader wellness needs of all employees.

The company rebranded as Work& earlier this year.

Rice biotech studio secures investment from Modi Ventures, adds founder to board

fresh funding

RBL LLC, which supports commercialization for ventures formed at the Rice University Biotech Launch Pad, has secured an investment from Houston-based Modi Ventures.

Additionally, RBL announced that it has named Sahir Ali, founder and general partner of Modi Ventures, to its board of directors.

Modi Ventures invests in biotech companies that are working to advance diagnostics, engineered therapeutics and AI-driven drug discovery. The firm has $134 million under management after closing an oversubscribed round this summer.

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. William McKeon, president and CEO of the TMC, previously called the launch of RBL a “critical step forward” for Houston’s life sciences ecosystem.

“RBL is dedicated to building companies focused on pioneering and intelligent bioelectronic therapeutics,” Ali said in a LinkedIn post. “This partnership strengthens the Houston biotech ecosystem and accelerates the transition of groundbreaking lab discoveries into impactful therapies.”

Ali will join board members like managing partner Paul Wotton, Rice bioengineering professor Omid Veiseh, scientist and partner at KdT Ventures Rima Chakrabarti, Rice alum John Jaggers, CEO of Arbor Biotechnologies Devyn Smith, and veteran executive in the life sciences sector James Watson.

Ali has led transformative work and built companies across AI, cloud computing and precision medicine. Ali also serves on the board of directors of the Drug Information Association, which helps to collaborate in drug, device and diagnostics developments.

“This investment by Modi Ventures will be instrumental to RBL’s growth as it reinforces confidence in our venture creation model and accelerates our ability to develop successful biotech startups,” Wotton said in the announcement. "Sahir’s addition to the board will also amplify this collaboration with Modi. His strategic counsel and deep understanding of field-defining technologies will be invaluable as we continue to grow and deliver on our mission.”